Lataa...
The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation
Sunitinib is approved for the treatment of metastatic renal cell carcinoma (RCC) and imatinib-resistant or -intolerant gastrointestinal stromal tumours (GIST). Several studies have identified unexpected rates of thyroid dysfunction with sunitinib treatment. We performed a prospective observational s...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2527784/ https://ncbi.nlm.nih.gov/pubmed/18665181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604497 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|